Qube Research & Technologies (QRT)
PASG icon

Qube Research & Technologies (QRT)’s Passage Bio PASG Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio PASG Stock Details PASG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Hold
0
– -$4 – 3902
2024
Q2 		– Hold
0
– – – 3660
2024
Q1 		– Hold
0
– – – 4329
2023
Q4 		– Hold
0
– – – 4218
2023
Q3 		– Hold
0
– – – 3991
2022
Q4 		– Sell
-1,506
Closed -$38K – 2858
2022
Q3 		$38K Sell
1,506
-189
-11% -$7.45K ﹤0.01% 2199
2022
Q2 		$80K Buy
+1,695
New +$79.2K ﹤0.01% 2017
2021
Q4 		– Sell
-1,156
Closed -$230K – 2857
2021
Q3 		$230K Buy
+1,156
New +$276K ﹤0.01% 1594

Other funds holding PASG

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Qube Research & Technologies (QRT)'s PASG Position: Q3 2024 in Review

Qube Research & Technologies (QRT) held its Passage Bio (PASG) position steady in Q3 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3902.

Qube Research & Technologies (QRT) first reported a position in PASG in Q3 2021 and has held it in 3 quarters since. The position peaked at $230K in Q3 2021. 44 funds tracked by Wall St. Rank hold PASG as of Q3 2024.

  • Qube Research & Technologies (QRT) held 0 shares of Passage Bio worth $0 as of Q3 2024.
  • Qube Research & Technologies (QRT) left its Passage Bio share count unchanged in Q3 2024.
  • Passage Bio made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2024, its #3902 holding.
  • Qube Research & Technologies (QRT) first reported a position in Passage Bio in Q3 2021 and has held it in 3 quarters since.
  • Qube Research & Technologies (QRT)'s Passage Bio position peaked at $230K in Q3 2021.
  • 44 funds tracked by Wall St. Rank held Passage Bio as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.